Article info
PDFReview
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure
- Correspondence to Dr Shruti S Joshi, BHF Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK; sjoshi{at}ed.ac.uk
Citation
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure
Publication history
- Received August 19, 2020
- Revised December 8, 2020
- Accepted December 14, 2020
- First published February 26, 2021.
Online issue publication
January 10, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.